|
1
|
Tanaka M, Fernández-Del Castillo C,
Kamisawa T, Jang JY, Levy P, Ohtsuka T, Salvia R, Shimizu Y, Tada M
and Wolfgang CL: Revision of international consensus Fukuoka
guidelines for the management of IPMN of the pancreas.
Pancreatology. 17:738–753. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Adsay V, Mino-Kenudson M, Furukawa T,
Basturk O, Zamboni G, Marchegiani G, Bassi C, Salvia R, Malleo G,
Paiella S, et al: Pathologic evaluation and reporting of
intraductal papillary mucinous neoplasms of the pancreas and other
tumoral intraepithelial neoplasms of pancreatobiliary tract:
Recommendations of verona consensus meeting. Ann Surg. 263:162–177.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Adsay NV, Merati K, Basturk O,
Iacobuzio-Donahue C, Levi E, Cheng JD, Sarkar FH, Hruban RH and
Klimstra DS: Pathologically and biologically distinct types of
epithelium in intraductal papillary mucinous neoplasms: Delineation
of an ‘intestinal’ pathway of carcinogenesis in the pancreas. Am J
Surg Pathol. 28:839–848. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Aronsson L, Andersson R and Ansari D:
Intraductal papillary mucinous neoplasm of the
pancreas-epidemiology, risk factors, diagnosis, and management.
Scand J Gastroenterol. 52:803–815. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kim J, Jang KT, Mo Park S, Lim SW, Kim JH,
Lee KH, Lee JK, Heo JS, Choi SH, Choi DW, et al: Prognostic
relevance of pathologic subtypes and minimal invasion in
intraductal papillary mucinous neoplasms of the pancreas. Tumour
Biol. 32:535–542. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
James D: Brierley and Marry K:
Gospodarowicz, Christian Wittekind. TMN Classification of Malignant
Tumors, 8th ed. New York, Wiley-Blackwell, 2016.
|
|
7
|
Sohn TA, Yeo CJ, Cameron JL, Hruban RH,
Fukushima N, Campbell KA and Lillemoe KD: Intraductal papillary
mucinous neoplasms of the pancreas an updated experience. Ann Surg.
239:788–797; discussion 797-9. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Murakami Y, Uemura K, Sudo T, Hayashidani
Y, Hashimoto Y, Nakashima A and Sueda T: Invasive intraductal
papillary-mucinous neoplasm of the pancreas: Comparison with
pancreatic ductal adenocarcinoma. J Surg Oncol. 100:13–18.
2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ueda N, Kaida D, Tomita Y, Ohnishi T,
Funaki H, Fujita H, Kinami S, Nakano Y and Kosaka T: A patient with
lnvasive carcinoma derived from IPMN who achieved long-term
survival despite lymph node metastasis. Gan To Kagaku Ryoho.
41:2202–2204. 2014.PubMed/NCBI(In Japanese).
|
|
10
|
Aşkan G, Bağci P, Memiş B and Baştürk O:
Intraductal neoplasms of the pancreas: An update. Turk Patoloji
Derg. 33:87–102. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Patel A, Lambiase L, Decarli A and Fazel
A: Management of the mucin filled bile duct. A complication of
intraductal papillary mucinous tumor of the pancreas. JOP.
6:255–259. 2005.PubMed/NCBI
|
|
12
|
Fritz S, Hackert T, Hinz U, Hartwig W,
Büchler MW and Werner J: Role of serum carbohydrate antigen 19-9
and carcinoembryonic antigen in distinguishing between benign and
invasive intraductal papillary mucinous neoplasm of the pancreas.
Br J Surg. 98:104–110. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Kim JR, Jang JY, Kang MJ, Park T, Lee SY,
Jung W, Chang J, Shin Y, Han Y and Kim SW: Clinical implication of
serum carcinoembryonic antigen and carbohydrate antigen 19-9 for
the prediction of malignancy in intraductal papillary mucinous
neoplasm of pancreas. J Hepatobiliary Pancreat Sci. 22:699–707.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Hirono S, Kawai M, Okada KI, Miyazawa M,
Shimizu A, Kitahata Y, Ueno M, Yanagisawa A and Yamaue H: Factors
associated with invasive intraductal papillary mucinous carcinoma
of the pancreas. JAMA Surg. 152(e165054)2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Furukawa T: Subtyping of IPMN. Methods Mol
Biol. 1882:1–8. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Castellano-Megías VM, Andrés CI,
López-Alonso G and Colina-Ruizdelgado F: Pathological features and
diagnosis of intraductal papillary mucinous neoplasm of the
pancreas. World J Gastrointest Oncol. 6:311–324. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Masuda A, Arisaka Y, Hara S, Matsumoto I,
Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, et
al: MUC2 expression and prevalence of high-grade dysplasia and
invasive carcinoma in mixed-type intraductal papillary mucinous
neoplasm of the pancreas. Pancreatology. 13:583–588.
2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tomimaru Y, Ishikawa O, Ohigashi H, Eguchi
H, Yamada T, Sasaki Y, Kishi K, Takachi K, Noura S, Miyashiro I, et
al: Intraductal papillary-mucinous carcinoma of the pancreas with
tumor thrombus in the portal vein: A report of two cases.
Hepatogastroenterology. 54:1585–1588. 2007.PubMed/NCBI
|
|
19
|
D'Angelica M, Brennan MF, Suriawinata AA,
Klimstra D and Conlon KC: Intraductal papillary mucinous neoplasms
of the pancreas: An analysis of clinicopathologic features and
outcome. Ann Surg. 239:400–408. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hirono S and Yamaue H: Surgical strategy
for intraductal papillary mucinous neoplasms of the pancreas. Surg
today. 50:50–55. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
McMillan MT, Lewis RS, Drebin JA,
Teitelbaum UR, Lee MK, Roses RE, Fraker DL and Vollmer CM: The
efficacy of adjuvant therapy for pancreatic invasive intraductal
papillary mucinous neoplasm (IPMN). Cancer. 122:521–533.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hirono S, Shimizu Y, Ohtsuka T, Kin T,
Hara K, Kanno A, Koshita S, Hanada K, Kitano M, Inoue H, et al:
Recurrence patterns after surgical resection of intraductal
papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter,
retrospective study of 1074 IPMN patients by the Japan Pancreas
Society. J Gastroentrol. 55:86–99. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ochiai T, Igari K, Furuyama T, Ito H,
Mitsunori Y, Aihara A, Kumagai Y, Iida M, Odajima H, Tanaka S, et
al: Favorable response after Gemcitabine-Radiotherapy for invasive
pancreatic intraductal papillary mucinous neoplasm: A case report.
Int Surg. 98:340–345. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kameyama S, Motonari H, Ishimine T and Isa
T: Successful treatment with conversion surgery following
chemoradiotherapy for unresectable invasive intraductal papillary
mucinous neoplasm. Clin J Gastroenterol. 13:579–584.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Marsoner K, Haybaeck J, Csengeri D, Waha
JE, Schagerl J, Langeder R, Mischinger HJ and Kornprat P:
Pancreatic resection for intraductal papillary mucinous neoplasm- a
thirteen-year single center experience. BMC Cancer.
16(844)2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Matsuda Y, Hagio M, Naito Z and Ishiwata
T: Clinicopathological features of 30 autopsy cases of pancreatic
carcinoma. J Nippon Med Sch. 79:459–467. 2012.PubMed/NCBI View Article : Google Scholar
|
